Brief: Glaukos Q2 Sales USD 80.4 Million Vs. IBES Estimate USD 74.7 Million
02/08/2023 21:05
Aug 02 (Reuters) - Glaukos Q2 adjusted gross margin 82%. * Q2 adjusted net income USD -26.6 million * Q2 gross margin 75% * Q2 net income USD -32.8 million * Outlook FY Sales USD 304-308 Million
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary